Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues [Abstract]
Product sales, net	$ 50,037,106
Revenue, Product and Service [Extensible Enumeration]	us-gaap:ProductMember
Operating expenses:
Cost of product sales (excluding amortization and depreciation)	$ 5,197,595
Cost, Product and Service [Extensible Enumeration]	us-gaap:ProductMember
Research and development	$ 57,947,447	$ 58,060,725	$ 70,244,579
Selling, general and administrative	159,253,661	66,646,205	28,896,749
Loss in fair value of contingent consideration	3,298,230
Intangible asset amortization	4,139,228
Total operating expenses	229,836,161	124,706,930	99,141,328
Loss from operations	(179,799,055)	(124,706,930)	(99,141,328)
Interest expense, net	(7,334,596)	(5,696,062)	(2,565,838)
Tax credit			53,578
Loss on extinguishment of debt			(1,247,012)
Net loss	$ (187,133,651)	$ (130,402,992)	$ (102,900,600)
Net loss per common share, basic	$ (4.60)	$ (3.47)	$ (2.77)
Net loss per common share, diluted	$ (4.60)	$ (3.47)	$ (2.77)
Weighted average common shares outstanding, basic	40,655,941	37,618,599	37,206,928
Weighted average common shares outstanding, diluted	40,655,941	37,618,599	37,206,928